Cardium Therapeutics Company Profile

02:56 EST 20th November 2017 | BioPortfolio

Cardium Therapeutics, Inc. is a medical technology company primarily focused on the development, manufacture and sale of innovative products for cardiovascular and related indications, which are leading healthcare priorities in the U.S. and the world. We are in the process of building a business that balances products for “today” that are either currently marketed or have advanced to near-term sales or partnering opportunities, as well as breakthrough products for “tomorrow”. We are leading a revolution into the new frontiers of cardiovascular and regenerative medicine and are assembling a portfolio of forward-focused therapeutic biologics and medical devices designed to transform the practice of medicine. They each have well-defined commercial pathways and represent substantial economic opportunities. While varied in approach, our portfolio is uniformly directed to the prevention and treatment of ischemic injuries. Our biologics and medical devices are designed to leverage the human body’s natural capacity to heal, protect and repair. Unlike small molecule, chronic-use drugs that typically provide only symptomatic relief, the planned products in our portfolio are being designed for one-time application to heal and repair the underlying medical condition or to prevent further injury in acute or surgical settings.


3611 Valley Centre, Suite 525
San Diego
United States of America


Phone: (858) 436-1000
Fax: (858) 436-1001

News Articles [531 Associated News Articles listed on BioPortfolio]

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Deals this week: Nabriva Therapeutics, LifeMine Therapeutics, Aldeyra Therapeutics

Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...

Taxus Cardium Pharmaceuticals Group Inc CRXM Financial and Strategic SWOT Analysis Review [Report Updated: 30082017] Prices from USD $125

Taxus Cardium Pharmaceuticals Group Inc CRXM Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has b...

Angina Angina Pectoris Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

DelveInsight's, Angina Angina Pectoris Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Angina Angina Pectoris. The key objective of the report is to e...

Breakfast Technical Briefing on Biotech Stocks -- Cytori Therapeutics, Sorrento Therapeutics, ... Cytori Therapeutics San Diego, Californiaheadquartered Cytori Therapeutics Inc.'s shares dropped 2.15%, closing Monday's trading session at $0.39. The stock ...

RaNA Therapeutics Relaunches as Translate Bio to Advance RNA Therapeutics

Tuesday, June 27th 2017 at 11:00am UTC — Company Expands Executive Leadership Team with Key Appointments in Early 2017 — CAMBRIDGE, Mass.–(BUSINESS WIRE)– RaNA Therapeutics tod...

SMi Group announces the 9th Annual RNA Therapeutics Conference

21 - 22 February 2018, London, UK. As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towar...

Clinical Trials [120 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1169 Associated Companies listed on BioPortfolio]

Cardium Therapeutics, Inc.

Cardium Therapeutics, Inc. and its subsidiaries, InnerCool Therapies, Inc. and the Tissue Repair Company, are medical technology companies primarily focused on the development, manufacture and sal...

Taxus Cardium Pharmaceuticals Group Inc.

Taxus Cardium Pharmaceuticals Group Inc. is a holding company that operates Cardium Therapeutics, a development stage advanced regenerative therapeutics company focused on the lat...

Cardium Therapeutics

Cardium Therapeutics, Inc. is a medical technology company primarily focused on the development, manufacture and sale of innovative products for cardiovascular and related indications, which are leadi...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "Cardium Therapeutics" on BioPortfolio

We have published hundreds of Cardium Therapeutics news stories on BioPortfolio along with dozens of Cardium Therapeutics Clinical Trials and PubMed Articles about Cardium Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cardium Therapeutics Companies in our database. You can also find out about relevant Cardium Therapeutics Drugs and Medications on this site too.

Quick Search

Relevant Topics

Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record